... cell and gene therapeutics using its proprietary genetic engineering platform technologies, received clearance in December 2021 by FDA for its ...
https://www.google.com/url?rct=j&sa=t&url=https://www.biopharminternational.com/view/fda-accepts-ind-for-poseida-therapeutics-allogeneic-car-t-cell-therapy-candidate&ct=ga&cd=CAIyGjg0YzkwMzEwZTQwYzQxNjA6Y29tOmVuOlVT&usg=AFQjCNFVvt7b7sjk2W04lp9VBcn_nbLxIw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.